Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe needle on the Mounjaro KwikPen is 4 mm long and 32 gauge — roughly the width of a human hair and shorter than most people imagine. That combination makes it one of the finer injection needles used in weight management, designed to reach the subcutaneous fat layer just beneath the skin without going deeper. Because these are prescription-only medicines, a clinical assessment with a GPhC-registered prescriber comes before any treatment starts; a prescriber decides whether Mounjaro is appropriate for you, and they're the right person to answer any technique questions specific to your situation. For a closer look at Mounjaro and how it works, that overview covers the full picture.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture a pen slightly chunkier than a marker. The needle is sealed inside the cap until the moment you inject; you won't see it beforehand, and that's deliberate. When the KwikPen is pressed against the skin and the button is pushed, a 4 mm, 32-gauge needle deploys, delivers the dose, and retracts. The entire injection takes a few seconds.
To put 4 mm in context: a standard blood-test needle is typically longer and wider. The 32-gauge width is close to the finest routinely manufactured for self-injection. Most people describe the sensation as a mild pinch or nothing at all, particularly once they've done it a few times. First-injection nerves tend to make it feel more significant than it is.
One checking habit worth building before every injection: hold the pen up to a light source and confirm the liquid in the window is clear and colourless with no visible particles. It takes under a minute and costs nothing. If the liquid looks cloudy, discoloured or contains flecks, don't inject, contact your prescriber. More detail on what the pen contains is on the Mounjaro injection ingredients page.
The needle is single-use. After injecting, place the pen directly into a sharps container, household bins aren't safe for used pens.
Mounjaro is injected subcutaneously, into the layer of fatty tissue that sits between the skin and the muscle. That layer is typically 4–8 mm deep even in leaner adults, so a 4 mm needle reliably reaches it without entering muscle, where absorption would be different and discomfort greater.
Intramuscular injections (the kind given in a clinic for some vaccines) use longer needles and deliberately target muscle. Subcutaneous injections for medicines like tirzepatide don't need that depth. The shorter needle also means there's less need to pinch the skin unless you have very little subcutaneous fat in the chosen site; your prescriber can advise based on your build.
Three sites are licensed for Mounjaro injections: the abdomen (at least a few centimetres from the navel), the front or outer thigh, and the upper arm. Rotating between them each week (not returning to the same spot in less than a month) gives the skin time to recover and keeps absorption consistent. Full guidance on injecting Mounjaro safely covers site choice and technique in more detail. The NHS tirzepatide patient information also covers injection sites in plain language.
Unlike some injectable medicines, the Mounjaro KwikPen doesn't require you to screw on a separate needle before each use. The needle is an integrated part of the pen's injection mechanism. What you do need to do is remove the outer and inner caps, check the dose window, and confirm the injection site is clean, an alcohol swab wiped over the skin and left to dry for a few seconds is the standard prep.
If you're wondering about the mechanics of attaching the needle on the Mounjaro pen, that page addresses pens where the needle cap is a separate component. The key point with the standard KwikPen is that the needle isn't user-replaceable mid-pen; each pen is a single unit used weekly, then disposed of. Some patients ask whether aftermarket needles are compatible, the answer is to follow the manufacturer's instructions and your prescriber's advice exactly. The Mounjaro pen needle page explains the pen's needle design in more detail.
Anxious about self-injecting? It's a common concern, and worth raising during your consultation. Prescribers hear it regularly. A short practice with the uncapped pen against a cushion can help build confidence before the first real dose.
Needle gauge and length are fixed in the KwikPen design, so there's no decision to make there. Where clinical judgement does come in: if you develop bruising, swelling or lumps at injection sites, if the injection is consistently painful in one location, or if you have a condition affecting skin or subcutaneous tissue, those are conversations for your prescriber rather than something to troubleshoot alone.
Mounjaro is a prescription-only medicine, weight management using tirzepatide requires a full clinical assessment, and the prescriber sets and reviews your dose at every stage. The Mounjaro needles guide covers additional practical questions, and this page on the injection needle goes deeper into the device specifics. The Mounjaro SmPC on the eMC is the definitive reference for storage, administration and full prescribing information.
If you're thinking about whether Mounjaro could be appropriate for you, speaking to our prescribers is the place to start, a free consultation, reviewed the same day by a real clinician.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.